Michael S. Brown, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 6,990 shares at $752.14 ($5.3M) on 2022-11-08, disclosed to the SEC on 2022-11-10.
Open-market sale of $5.3M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $748.48 | 1,764 | $1.3M | 25.1% |
| 2 | $748.48 | 1,764 | $1.3M | 25.1% |
| 3 | $748.49 | 500 | $374K | 7.1% |
| 4 | $751.23 | 126 | $95K | 1.8% |
| 5 | $751.23 | 126 | $95K | 1.8% |
| 6 | $752.14 | 203 |
| $153K |
| 2.9% |
| 7 | $752.14 | 203 | $153K | 2.9% |
| 8 | $753.66 | 300 | $226K | 4.3% |
| 9 | $754.70 | 200 | $151K | 2.9% |
| 10 | $760.70 | 200 | $152K | 2.9% |
| 11 | $761.53 | 100 | $76K | 1.4% |
| 12 | $763.19 | 200 | $153K | 2.9% |
| 13 | $764.23 | 200 | $153K | 2.9% |
| 14 | $765.19 | 100 | $77K | 1.5% |
| 15 | $766.74 | 201 | $154K | 2.9% |
| 16 | $766.74 | 201 | $154K | 2.9% |
| 17 | $767.25 | 201 | $154K | 2.9% |
| 18 | $767.25 | 201 | $154K | 2.9% |
| 19 | $768.11 | 200 | $154K | 2.9% |
| Total | $753.53 avg | 6,990 | $5.3M | 100% |
| Filing → |
| REGN | SELL | 2023-12-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-04-24 | $4.9M | — | Filing → |
| REGN | SELL | 2023-02-08 | $2.8M | — | Filing → |